Key result
Pre-existing diabetes mellitus in STEMI patients was associated with a higher risk of major adverse cardiovascular events compared to nondiabetic patients (32% vs 11%; P<0.001).
Why the study?
Does hyperglycemia on admission increase the risk of major adverse cardiovascular events and myocardial damage in STEMI patients with and without diabetes?
Population
411 consecutive STEMI patients reperfused by primary angioplasty
Comparison
Hyperglycemia on admission vs Normoglycemia on admission
Design
Cohort
Follow-up
long-term
Authors
Loading...
Admission hyperglycemia signals greater injury and events in STEMI, stronger in nondiabetics; supports targeted glycemic studies but should not yet change practice.
Cohort (n=411)
Does hyperglycemia on admission increase the risk of major adverse cardiovascular events and myocardial damage in STEMI patients with and without diabetes?
Absolute Event Rate: 32% vs 11%
p-value: p=<0.001
Hyperglycemia on admission in STEMI patients is associated with greater myocardial injury and long-term MACE, with a lower glucose threshold for harm in nondiabetic compared to diabetic patients.
Eitel et al. (2012) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=411). Pre-existing diabetes mellitus and admission hyperglycemia vs. Nondiabetic patients and normoglycemia was evaluated on occurrence of major adverse cardiovascular events at long-term follow-up (p=<0.001). Pre-existing diabetes mellitus in STEMI patients was associated with a higher risk of major adverse cardiovascular events compared to nondiabetic patients (32% vs 11%; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: